- The only HIV vaccine in advanced trials has failed. Now what? New York Times
- J&J packages HIV vaccine after failure of Phase 3 FierceBiotech trial
- Experimental HIV vaccine regimen safe but ineffective, National Institutes of Health (.gov) study finds
- J&J to end HIV vaccine trial Reuters
- Johnson & Johnson cuts production of COVID vaccine amid drop in demand NJ.com
- See full coverage on Google News
Add Comment